調査レポート | • レポートコード：GIR-2104Z10772 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペット用がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペット用がん治療薬の種類別市場規模（化学療法、標的療法、併用療法、免疫療法）、用途別市場規模（リンパ腫、肥満細胞がん、黒色腫、乳腺、扁平上皮がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペット用がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aratana Therapeutics, Inc、AB Science、Boehringer Ingelheim International GmbH、Zenoaq、Morphogenesis, Inc、VetDC, Inc、Karyopharm Therapeutics, Inc、Rhizen Pharmaceutical SA、Regeneus Ltd.、Oasmia Pharmaceuticals AB、Zoetis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、標的療法、併用療法、免疫療法 ・用途別分析2016年-2026年：リンパ腫、肥満細胞がん、黒色腫、乳腺、扁平上皮がん、その他 ・ペット用がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペット用がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペット用がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペット用がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペット用がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pet Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pet Cancer Therapeutics size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pet Cancer Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pet Cancer Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Market segment by Application can be divided into
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others
The key market players for global Pet Cancer Therapeutics market are listed below:
Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pet Cancer Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pet Cancer Therapeutics Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Combination Therapy
1.2.5 Immunotherapy
1.3 Market Analysis by Application
1.3.1 Overview: Global Pet Cancer Therapeutics Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Lymphoma
1.3.3 Mast Cell Cancer
1.3.4 Melanoma
1.3.5 Mammary
1.3.6 Squamous Cell Cancer
1.3.7 Others
1.4 Global Pet Cancer Therapeutics Market Size & Forecast
1.4.1 Global Pet Cancer Therapeutics Sales in Value (2016-2026))
1.4.2 Global Pet Cancer Therapeutics Sales in Volume (2016-2026)
1.4.3 Global Pet Cancer Therapeutics Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pet Cancer Therapeutics Production Capacity Analysis
1.5.1 Global Pet Cancer Therapeutics Total Production Capacity (2016-2026)
1.5.2 Global Pet Cancer Therapeutics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pet Cancer Therapeutics Market Drivers
1.6.2 Pet Cancer Therapeutics Market Restraints
1.6.3 Pet Cancer Therapeutics Trends Analysis
2 Manufacturers Profiles
2.1 Aratana Therapeutics, Inc
2.1.1 Aratana Therapeutics, Inc Details
2.1.2 Aratana Therapeutics, Inc Major Business
2.1.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Product and Services
2.1.4 Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 AB Science
2.2.1 AB Science Details
2.2.2 AB Science Major Business
2.2.3 AB Science Pet Cancer Therapeutics Product and Services
2.2.4 AB Science Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boehringer Ingelheim International GmbH
2.3.1 Boehringer Ingelheim International GmbH Details
2.3.2 Boehringer Ingelheim International GmbH Major Business
2.3.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product and Services
2.3.4 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Zenoaq
2.4.1 Zenoaq Details
2.4.2 Zenoaq Major Business
2.4.3 Zenoaq Pet Cancer Therapeutics Product and Services
2.4.4 Zenoaq Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Morphogenesis, Inc
2.5.1 Morphogenesis, Inc Details
2.5.2 Morphogenesis, Inc Major Business
2.5.3 Morphogenesis, Inc Pet Cancer Therapeutics Product and Services
2.5.4 Morphogenesis, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 VetDC, Inc
2.6.1 VetDC, Inc Details
2.6.2 VetDC, Inc Major Business
2.6.3 VetDC, Inc Pet Cancer Therapeutics Product and Services
2.6.4 VetDC, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Karyopharm Therapeutics, Inc
2.7.1 Karyopharm Therapeutics, Inc Details
2.7.2 Karyopharm Therapeutics, Inc Major Business
2.7.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product and Services
2.7.4 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Rhizen Pharmaceutical SA
2.8.1 Rhizen Pharmaceutical SA Details
2.8.2 Rhizen Pharmaceutical SA Major Business
2.8.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product and Services
2.8.4 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Regeneus Ltd.
2.9.1 Regeneus Ltd. Details
2.9.2 Regeneus Ltd. Major Business
2.9.3 Regeneus Ltd. Pet Cancer Therapeutics Product and Services
2.9.4 Regeneus Ltd. Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Oasmia Pharmaceuticals AB
2.10.1 Oasmia Pharmaceuticals AB Details
2.10.2 Oasmia Pharmaceuticals AB Major Business
2.10.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product and Services
2.10.4 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Zoetis
2.11.1 Zoetis Details
2.11.2 Zoetis Major Business
2.11.3 Zoetis Pet Cancer Therapeutics Product and Services
2.11.4 Zoetis Pet Cancer Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pet Cancer Therapeutics Sales by Manufacturer
3.1 Global Pet Cancer Therapeutics Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pet Cancer Therapeutics Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pet Cancer Therapeutics
3.4 Market Concentration Rate
3.4.1 Top 3 Pet Cancer Therapeutics Manufacturer Market Share
3.4.2 Top 6 Pet Cancer Therapeutics Manufacturer Market Share
3.5 Global Pet Cancer Therapeutics Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pet Cancer Therapeutics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pet Cancer Therapeutics Market Size by Region
4.1.1 Global Pet Cancer Therapeutics Sales in Volume by Region (2016-2026)
4.1.2 Global Pet Cancer Therapeutics Revenue by Region (2016-2026)
4.2 North America Pet Cancer Therapeutics Revenue (2016-2026)
4.3 Europe Pet Cancer Therapeutics Revenue (2016-2026)
4.4 Asia-Pacific Pet Cancer Therapeutics Revenue (2016-2026)
4.5 South America Pet Cancer Therapeutics Revenue (2016-2026)
4.6 Middle East and Africa Pet Cancer Therapeutics Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pet Cancer Therapeutics Sales in Volume by Type (2016-2026)
5.2 Global Pet Cancer Therapeutics Revenue by Type (2016-2026)
5.3 Global Pet Cancer Therapeutics Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pet Cancer Therapeutics Sales in Volume by Application (2016-2026)
6.2 Global Pet Cancer Therapeutics Revenue by Application (2016-2026)
6.3 Global Pet Cancer Therapeutics Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pet Cancer Therapeutics Sales by Type (2016-2026)
7.2 North America Pet Cancer Therapeutics Sales by Application (2016-2026)
7.3 North America Pet Cancer Therapeutics Market Size by Country
7.3.1 North America Pet Cancer Therapeutics Sales in Volume by Country (2016-2026)
7.3.2 North America Pet Cancer Therapeutics Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pet Cancer Therapeutics Sales by Type (2016-2026)
8.2 Europe Pet Cancer Therapeutics Sales by Application (2016-2026)
8.3 Europe Pet Cancer Therapeutics Market Size by Country
8.3.1 Europe Pet Cancer Therapeutics Sales in Volume by Country (2016-2026)
8.3.2 Europe Pet Cancer Therapeutics Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pet Cancer Therapeutics Sales by Type (2016-2026)
9.2 Asia-Pacific Pet Cancer Therapeutics Sales by Application (2016-2026)
9.3 Asia-Pacific Pet Cancer Therapeutics Market Size by Region
9.3.1 Asia-Pacific Pet Cancer Therapeutics Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pet Cancer Therapeutics Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pet Cancer Therapeutics Sales by Type (2016-2026)
10.2 South America Pet Cancer Therapeutics Sales by Application (2016-2026)
10.3 South America Pet Cancer Therapeutics Market Size by Country
10.3.1 South America Pet Cancer Therapeutics Sales in Volume by Country (2016-2026)
10.3.2 South America Pet Cancer Therapeutics Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pet Cancer Therapeutics Sales by Type (2016-2026)
11.2 Middle East & Africa Pet Cancer Therapeutics Sales by Application (2016-2026)
11.3 Middle East & Africa Pet Cancer Therapeutics Market Size by Country
11.3.1 Middle East & Africa Pet Cancer Therapeutics Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pet Cancer Therapeutics Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pet Cancer Therapeutics Typical Distributors
12.3 Pet Cancer Therapeutics Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pet Cancer Therapeutics Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pet Cancer Therapeutics Revenue by Application, (USD Million), 2021-2026
Table 3. Aratana Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Aratana Therapeutics, Inc Major Business
Table 5. Aratana Therapeutics, Inc Pet Cancer Therapeutics Product and Services
Table 6. Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AB Science Basic Information, Manufacturing Base and Competitors
Table 8. AB Science Major Business
Table 9. AB Science Pet Cancer Therapeutics Product and Services
Table 10. AB Science Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim International GmbH Major Business
Table 13. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product and Services
Table 14. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Zenoaq Basic Information, Manufacturing Base and Competitors
Table 16. Zenoaq Major Business
Table 17. Zenoaq Pet Cancer Therapeutics Product and Services
Table 18. Zenoaq Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Morphogenesis, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Morphogenesis, Inc Major Business
Table 21. Morphogenesis, Inc Pet Cancer Therapeutics Product and Services
Table 22. Morphogenesis, Inc Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. VetDC, Inc Basic Information, Manufacturing Base and Competitors
Table 24. VetDC, Inc Major Business
Table 25. VetDC, Inc Pet Cancer Therapeutics Product and Services
Table 26. VetDC, Inc Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Karyopharm Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 28. Karyopharm Therapeutics, Inc Major Business
Table 29. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product and Services
Table 30. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Rhizen Pharmaceutical SA Basic Information, Manufacturing Base and Competitors
Table 32. Rhizen Pharmaceutical SA Major Business
Table 33. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product and Services
Table 34. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Regeneus Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Regeneus Ltd. Major Business
Table 37. Regeneus Ltd. Pet Cancer Therapeutics Product and Services
Table 38. Regeneus Ltd. Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Oasmia Pharmaceuticals AB Basic Information, Manufacturing Base and Competitors
Table 40. Oasmia Pharmaceuticals AB Major Business
Table 41. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product and Services
Table 42. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Zoetis Basic Information, Manufacturing Base and Competitors
Table 44. Zoetis Major Business
Table 45. Zoetis Pet Cancer Therapeutics Product and Services
Table 46. Zoetis Pet Cancer Therapeutics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Pet Cancer Therapeutics Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Pet Cancer Therapeutics Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Pet Cancer Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Pet Cancer Therapeutics Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Pet Cancer Therapeutics Production Site of Key Manufacturer
Table 52. Global Pet Cancer Therapeutics Sales by Region (2016-2021e) & (K Units)
Table 53. Global Pet Cancer Therapeutics Sales by Region (2021-2026) & (K Units)
Table 54. Global Pet Cancer Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Pet Cancer Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Pet Cancer Therapeutics Sales by Type (2016-2021e) & (K Units)
Table 57. Global Pet Cancer Therapeutics Sales by Type (2021-2026) & (K Units)
Table 58. Global Pet Cancer Therapeutics Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Pet Cancer Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Pet Cancer Therapeutics Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Pet Cancer Therapeutics Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Pet Cancer Therapeutics Sales by Application (2016-2021e) & (K Units)
Table 63. Global Pet Cancer Therapeutics Sales by Application (2021-2026) & (K Units)
Table 64. Global Pet Cancer Therapeutics Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Pet Cancer Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Pet Cancer Therapeutics Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Pet Cancer Therapeutics Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Pet Cancer Therapeutics Sales by Country (2016-2021e) & (K Units)
Table 69. North America Pet Cancer Therapeutics Sales by Country (2021-2026) & (K Units)
Table 70. North America Pet Cancer Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Pet Cancer Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Pet Cancer Therapeutics Sales by Type (2016-2021e) & (K Units)
Table 73. North America Pet Cancer Therapeutics Sales by Type (2021-2026) & (K Units)
Table 74. North America Pet Cancer Therapeutics Sales by Application (2016-2021e) & (K Units)
Table 75. North America Pet Cancer Therapeutics Sales by Application (2021-2026) & (K Units)
Table 76. Europe Pet Cancer Therapeutics Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Pet Cancer Therapeutics Sales by Country (2021-2026) & (K Units)
Table 78. Europe Pet Cancer Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Pet Cancer Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Pet Cancer Therapeutics Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Pet Cancer Therapeutics Sales by Type (2021-2026) & (K Units)
Table 82. Europe Pet Cancer Therapeutics Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Pet Cancer Therapeutics Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Pet Cancer Therapeutics Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Pet Cancer Therapeutics Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Pet Cancer Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Pet Cancer Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Pet Cancer Therapeutics Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Pet Cancer Therapeutics Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Pet Cancer Therapeutics Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Pet Cancer Therapeutics Sales by Application (2021-2026) & (K Units)
Table 92. South America Pet Cancer Therapeutics Sales by Country (2016-2021e) & (K Units)
Table 93. South America Pet Cancer Therapeutics Sales by Country (2021-2026) & (K Units)
Table 94. South America Pet Cancer Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Pet Cancer Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Pet Cancer Therapeutics Sales by Type (2016-2021e) & (K Units)
Table 97. South America Pet Cancer Therapeutics Sales by Type (2021-2026) & (K Units)
Table 98. South America Pet Cancer Therapeutics Sales by Application (2016-2021e) & (K Units)
Table 99. South America Pet Cancer Therapeutics Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Pet Cancer Therapeutics Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Pet Cancer Therapeutics Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Pet Cancer Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Pet Cancer Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Pet Cancer Therapeutics Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Pet Cancer Therapeutics Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Pet Cancer Therapeutics Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Pet Cancer Therapeutics Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Pet Cancer Therapeutics Typical Distributors
Table 111. Pet Cancer Therapeutics Typical Customers
List of Figures
Figure 1. Pet Cancer Therapeutics Picture
Figure 2. Global Pet Cancer Therapeutics Sales Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Targeted Therapy
Figure 5. Combination Therapy
Figure 6. Immunotherapy
Figure 7. Global Pet Cancer Therapeutics Sales Market Share by Application in 2020
Figure 8. Lymphoma
Figure 9. Mast Cell Cancer
Figure 10. Melanoma
Figure 11. Mammary
Figure 12. Squamous Cell Cancer
Figure 13. Others
Figure 14. Global Pet Cancer Therapeutics Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Pet Cancer Therapeutics Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Pet Cancer Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Pet Cancer Therapeutics Sales (2016-2026) & (K Units)
Figure 36. Global Pet Cancer Therapeutics Production Capacity (2016-2026) & (K Units)
Figure 37. Global Pet Cancer Therapeutics Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Pet Cancer Therapeutics Market Drivers
Figure 39. Pet Cancer Therapeutics Market Restraints
Figure 40. Pet Cancer Therapeutics Market Trends
Figure 41. Global Pet Cancer Therapeutics Sales Market Share by Manufacturer in 2020
Figure 42. Global Pet Cancer Therapeutics Revenue Market Share by Manufacturer in 2020
Figure 43. Pet Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Pet Cancer Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Pet Cancer Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Pet Cancer Therapeutics Sales Market Share by Region (2016-2026)
Figure 47. Global Pet Cancer Therapeutics Revenue Market Share by Region (2016-2026)
Figure 48. North America Pet Cancer Therapeutics Revenue (2016-2026) & (USD Million)
Figure 49. Europe Pet Cancer Therapeutics Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Pet Cancer Therapeutics Revenue (2016-2026) & (USD Million)
Figure 51. South America Pet Cancer Therapeutics Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Pet Cancer Therapeutics Revenue (2016-2026) & (USD Million)
Figure 53. Global Pet Cancer Therapeutics Sales Market Share by Type (2016-2026)
Figure 54. Global Pet Cancer Therapeutics Revenue Market Share by Type (2016-2026)
Figure 55. Global Pet Cancer Therapeutics Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Pet Cancer Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Global Pet Cancer Therapeutics Revenue Market Share by Application (2016-2026)
Figure 58. Global Pet Cancer Therapeutics Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Pet Cancer Therapeutics Sales Market Share by Country (2016-2026)
Figure 60. North America Pet Cancer Therapeutics Revenue Market Share by Country (2016-2026)
Figure 61. North America Pet Cancer Therapeutics Sales Market Share by Type (2016-2026)
Figure 62. North America Pet Cancer Therapeutics Sales Market Share by Application (2016-2026)
Figure 63. Europe Pet Cancer Therapeutics Sales Market Share by Country (2016-2026)
Figure 64. Europe Pet Cancer Therapeutics Revenue Market Share by Country (2016-2026)
Figure 65. Europe Pet Cancer Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. Europe Pet Cancer Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Pet Cancer Therapeutics Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Pet Cancer Therapeutics Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Pet Cancer Therapeutics Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Pet Cancer Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. South America Pet Cancer Therapeutics Sales Market Share by Country (2016-2026)
Figure 72. South America Pet Cancer Therapeutics Revenue Market Share by Country (2016-2026)
Figure 73. South America Pet Cancer Therapeutics Sales Market Share by Type (2016-2026)
Figure 74. South America Pet Cancer Therapeutics Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Pet Cancer Therapeutics Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Pet Cancer Therapeutics Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Pet Cancer Therapeutics Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Pet Cancer Therapeutics Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の扁平上皮非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Squamous Non-Small Cell Lung Cancer Therapeutics Market The global Squamous Non-Small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…- 世界の移行細胞がん治療薬市場規模・現状・予測（2021年-2027年） Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra. Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. Mar…
- 世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の移行上皮がん治療薬市場 2021：企業別、地域別、種類・用途別 The Transitional Cell Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…